Toll-Like Receptors (TLRs) and Innate Immunity

  • Stefan Bauer
  • Gunther Hartmann

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 183)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Satoshi Uematsu, Shizuo Akira
    Pages 1-20
  3. Constantinos Brikos, Luke A. J. O’Neill
    Pages 21-50
  4. Thomas Müller, Svetlana Hamm, Stefan Bauer
    Pages 51-70
  5. Veit Hornung, Winfried Barchet, Martin Schlee, Gunther Hartmann
    Pages 71-86
  6. Helen S. Goodridge, David M. Underhill
    Pages 87-109
  7. Alexzander Asea
    Pages 111-127
  8. Hubertus Hochrein, Meredith O’Keeffe
    Pages 153-179
  9. Nicholas J. Gay, Monique Gangloff
    Pages 181-200
  10. Steve Pascolo
    Pages 221-235
  11. Back Matter
    Pages 237-240

About this book


Overall recent research on TLRs has led to tremendous increase in our understanding of early steps in pathogen recognition and will presumably lead to potent TLR targeting therapeutics in the future. This book reviews and highlights our recent understanding on the function and ligands of TLRs as well as their role in autoimmunity, dendritic cell activation and target structures for therapeutic intervention.


Autoimmunity Dendritic Cells Immunotherapy Innate Immunity Toll-like Receptors lead

Editors and affiliations

  • Stefan Bauer
    • 1
  • Gunther Hartmann
    • 2
  1. 1.Institut für Immunologie BMFZPhilipps-Universität MarburgMarburgGermany
  2. 2.Abteilung für Klinische PharmakologieUniversitätsklinikum BonnBonnGermany

Bibliographic information